The use of postnatal dexamethasone in premature newborns can be associated with a
deleterious neurodevelopmental outcome. The effect of hydrocortisone on developmental …

Type of investigation: Prognosis; exploratory secondary analysis of an interventional
randomized controlled trial. Question: In extremely preterm infant (< 28 weeks), is early low …

Objective To determine whether early hydrocortisone treatment in extremely preterm infants
affects neurodevelopmental outcomes at 2 years of age according to gestational age at birth …

Importance Dexamethasone to prevent bronchopulmonary dysplasia in very preterm
neonates was associated with adverse neurodevelopmental events. Early low-dose …

Extremely low birth weight premature infants are at risk for poor neurodevelopmental
outcome. Postnatal dexamethasone has often been used in premature infants to prevent or …

OBJECTIVE: To investigate neurodevelopment at school age in preterm infants treated with
hydrocortisone for bronchopulmonary dysplasia (BPD) in the neonatal period. STUDY …

2. Methods This retrospective study included very-low-birth-weight (VLBW) infants who were
born between 2008 and 2015 and received hydrocortisone treatment at the neonatal …

The administration of dexamethasone has been associated with suboptimal
neurodevelopment. We aimed to compare the development of extremely premature infants …

Hydrocortisone is used in preterm infants. However, early disruption of growth velocities was
observed in infants exposed to hydrocortisone. This retrospective study aimed to explore the …

Objective: To assess the effect of moderately early postnatal dexamethasone treatment on
growth and neurodevelopmental outcome in preterm infants. Methods: Thirty preterm infants …